Stratos Wealth Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$356K Buy
4,105
+69
+2% +$6.61K 0.02% 450
2025
Q4
$388K Sell
4,036
-1,180
-23% -$115K 0.02% 486
2025
Q3
$497K Sell
5,216
-910
-15% -$83.7K 0.02% 464
2025
Q2
$534K Sell
6,126
-729
-11% -$61.8K 0.03% 437
2025
Q1
$616K Buy
6,855
+293
+4% +$26.2K 0.03% 396
2024
Q4
$524K Sell
6,562
-5,844
-47% -$506K 0.03% 457
2024
Q3
$1.12M Buy
12,406
+4,565
+58% +$384K 0.05% 331
2024
Q2
$617K Sell
7,841
-2,614
-25% -$214K 0.03% 423
2024
Q1
$911K Sell
10,455
-753
-7% -$64.3K 0.05% 346
2023
Q4
$923K Sell
11,208
-2,019
-15% -$154K 0.05% 343
2023
Q3
$1.04M Buy
13,227
+151
+1% +$12.6K 0.07% 294
2023
Q2
$1.15M Sell
13,076
-1,248
-9% -$107K 0.08% 271
2023
Q1
$1.15M Buy
14,324
+1,314
+10% +$107K 0.09% 254
2022
Q4
$1.01M Sell
13,010
-3,063
-19% -$248K 0.08% 276
2022
Q3
$1.3M Sell
16,073
-5,760
-26% -$518K 0.14% 201
2022
Q2
$1.96M Buy
21,833
+359
+2% +$36.4K 0.18% 151
2022
Q1
$2.38M Buy
21,474
+252
+1% +$26.6K 0.19% 137
2021
Q4
$2.19M Buy
21,222
+1,184
+6% +$137K 0.16% 172
2021
Q3
$2.51M Buy
20,038
+5,512
+38% +$713K 0.21% 129
2021
Q2
$1.8M Buy
14,526
+3,417
+31% +$429K 0.16% 169
2021
Q1
$1.31M Buy
11,109
+579
+5% +$67.9K 0.14% 181
2020
Q4
$1.23M Buy
10,530
+5,017
+91% +$552K 0.17% 140
2020
Q3
$573K Sell
5,513
-476
-8% -$47.8K 0.14% 164
2020
Q2
$549K Buy
5,989
+1,766
+42% +$169K 0.17% 132
2020
Q1
$381K Buy
4,223
+104
+3% +$11.1K 0.27% 91
2019
Q4
$467K Sell
4,119
-728
-15% -$79.9K 0.26% 83
2019
Q3
$527K Sell
4,847
-296
-6% -$30.9K 0.2% 108
2019
Q2
$501K Sell
5,143
-68
-1% -$6.21K 0.2% 115
2019
Q1
$475K Buy
5,211
+41
+0.8% +$3.67K 0.26% 105
2018
Q4
$470K Buy
+5,170
New +$483K 0.31% 95

Other funds holding MDT

Stratos Wealth Advisors's MDT Position: Q1 2026 in Review

Stratos Wealth Advisors increased its Medtronic (MDT) stake by 1.7% in Q1 2026, buying an estimated $6.61K and bringing the position to 4,105 shares worth $356K. The position accounts for 0.02% of the portfolio, ranked #450.

Stratos Wealth Advisors first reported a position in MDT in Q4 2018 and has held it in 30 quarters since. The position peaked at $2.51M in Q3 2021. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Stratos Wealth Advisors held 4,105 shares of Medtronic worth $356K as of Q1 2026.
  • Stratos Wealth Advisors bought 69 Medtronic shares in Q1 2026, an estimated $6.61K.
  • Medtronic made up 0.02% of Stratos Wealth Advisors's portfolio in Q1 2026, its #450 holding.
  • Stratos Wealth Advisors first reported a position in Medtronic in Q4 2018 and has held it in 30 quarters since.
  • Stratos Wealth Advisors's Medtronic position peaked at $2.51M in Q3 2021.
  • 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Stratos Wealth Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.